peptide elongation factor 2 has been researched along with alpha-aminopyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apaja, PM; Bidaud-Meynard, A; Guo, J; Hartman, JL; Icyuz, M; Lin, ST; Lukacs, GL; Oliver, K; Perdomo, D; Sorscher, EJ; Veit, G | 1 |
1 other study(ies) available for peptide elongation factor 2 and alpha-aminopyridine
Article | Year |
---|---|
Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect.
Topics: Aminopyridines; ATP-Binding Cassette Transporters; Benzodioxoles; Bronchi; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Knockdown Techniques; Gene Silencing; High-Throughput Screening Assays; Humans; Peptide Elongation Factor 2; Protein Folding; Protein Stability; Ribosomal Proteins; RNA, Small Interfering; Saccharomyces cerevisiae Proteins; Yeasts | 2016 |